July 24, 2019Open Access

Dolutegravir plus Two Different Prodrugs of Tenofovir to Treat HIV

Key Points

Key points are not available for this paper at this time.

Abstract

Treatment with DTG combined with either of two tenofovir prodrugs (TAF and TDF) showed noninferior efficacy to treatment with the standard-care regimen. There was significantly more weight gain with the DTG-containing regimens, especially in combination with TAF, than with the standard-care regimen. (ADVANCE ClinicalTrials.gov number, NCT03122262.).

Dolutegravir plus Two Different Prodrugs of Tenofovir to Treat HIV

Key Points

Abstract

Cite This Study